Overview


According to FutureWise analysis the market for neuroscience antibodies and assays in 2023 is US$ 4.18 billion, and is expected to reach US$ 9.24 billion by 2031 at a CAGR of 10.4%.

The study of the structure and functions of the human brain and nervous system is referred to as neuroscience. The research in this paper is entirely based on tests and antibodies. It necessitates a comprehensive examination of multiple cell types, organs, and tissues. Specific antibodies and tests aid in the identification and investigation of reactions at the cellular, molecular, and biochemical levels. Isolation and localization are accomplished using antibody-based methods. While using assays to determine important targets involved in brain development, synaptic transmission, and neurodegeneration is a helpful and efficient option. The study of the structure and functions of the human brain and nervous system is referred to as neuroscience. The research in this paper is entirely based on tests and antibodies. It necessitates a comprehensive examination of multiple cell types, organs, and tissues. Specific antibodies and tests aid in the identification and investigation of reactions at the cellular, molecular, and biochemical levels. Isolation and localization are accomplished using antibody-based methods. While using assays to determine important targets involved in brain development, synaptic transmission, and neurodegeneration is a helpful and efficient option. The World Health Organization (WHO) believes that up to one billion people worldwide are affected by neurological illnesses. Epilepsy, multiple sclerosis, Parkinson's disease, stroke, and traumatic brain injuries are common neurological disorders that afflict people in both industrialised and developing countries.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Neuroscience Antibodies and Assays Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Neuroscience Antibodies and Assays Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific
  • Abcam
  • Bio-Rad
  • Merck KGaA
  • BioLegend
  • Cell Signaling Technology
  • F. Hoffmann-La Roche
  • GenScript
  • Coty Inc.
  • Cutera
  • Rockland Immunochemicals
  • Siemens
  • Tecan

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Consumables
    • Reagents
      • Media and Sera
      • Stains and Dyes
      • Fixatives
      • Buffers
      • Solvents
      • Probes
      • Enzymes, Proteins, and Peptides
      • Other Reagents
    • Antibodies
      • Primary antibodies
      • Secondary Antibodies
    • Assay Kits
  • Instruments
    • Microplate Readers
    • Immunoassay Analyzers
    • Other Instruments

By Technology

  • Immunochemistry/Immunoassays
    • ELISA
    • Western Blotting
    • Others Immunoassays Technologies
  • Molecular Diagnostics
  • Clinical Chemistry
  • Other Technologies

By Application

  • Research
  • In Vitro Diagnostics
  • Drug Discovery and Development

By End User 

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Neuroscience Antibodies and Assays Market By Product, By Technology, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Neuroscience Antibodies and Assays Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neuroscience Antibodies
      Assays Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Neuroscience Antibodies and Assays Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Neuroscience Antibodies and Assays Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Consumables
         1.1. Reagents
          1.1.1. Media and Sera
          1.1.2. Stains and Dyes
          1.1.3. Fixatives
          1.1.4. Buffers
          1.1.5. Solvents
          1.1.6. Probes
          1.1.7. Enzymes, Proteins, and Peptides
          1.1.8. Other Reagents
         2.1. Antibodies
          2.1.1. Primary antibodies
          2.1.2. Secondary Antibodies
         3.1. Assay Kits
        2. Instruments
         2.1. Microplate Readers
         2.2. Immunoassay Analyzers
         2.3. Other Instruments

  • 8.   Neuroscience Antibodies and Assays Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunochemistry/Immunoassays
         1.1. ELISA
         1.2. Western Blotting
         1.3. Others Immunoassays Technologies
        2. Molecular Diagnostics
        3. Clinical Chemistry
        4. Other Technologies

  • 9.   Neuroscience Antibodies and Assays Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research
        2. In Vitro Diagnostics
        3. Drug Discovery and Development

  • 10.   Neuroscience Antibodies and Assays Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. Academic and Research Institutes
        3. Hospitals and Diagnostic Centers

  • 11.   North America Neuroscience Antibodies and Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Neuroscience Antibodies and Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Neuroscience Antibodies and Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Neuroscience Antibodies and Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abcam
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bio-Rad
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BioLegend
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cell Signaling Technology
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. F. Hoffmann-La Roche
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GenScript
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Coty Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cutera
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Rockland Immunochemicals
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Siemens
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Tecan
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients